CLINICAL TRIALS PROFILE FOR DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Formulation | NCT01889173 ↗ | Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy Adults | Completed | Tonix Pharmaceuticals, Inc. | Phase 1 | 2013-06-01 | Very low dose (VLD) cyclobenzaprine at bedtime has shown promise as a treatment for fibromyalgia, but the chemistry of cyclobenzaprine requires new formulation technology for bedtime use. The present trial is designed to assess the safety and tolerability of 3 different formulations of TNX-102 2.8 mg SL Tablets (a new formulation of cyclobenzaprine designed to result in increased dosage precision and decreased potential for morning grogginess) and to compare the bio-availability of 3 different formulations of TNX-102 2.8 mg SL Tablets (TNX-102 with potassium phosphate, TNX-102-B with sodium phosphate, and TNX-102-C with trisodium citrate) to that of cyclobenzaprine (5 mg tablets). |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004284 ↗ | Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 | 1995-04-01 | OBJECTIVES: I. Evaluate the ability of a slow-releasing formulation of neutral potassium phosphate to correct hypercalciuria and prevent recurrent stone formation in patients with absorptive hypercalciuria. II. Evaluate the safety of this treatment. III. Compare the efficacy of potassium phosphate to that of potassium citrate. |
| NCT00004284 ↗ | Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria | Completed | University of Texas | Phase 3 | 1995-04-01 | OBJECTIVES: I. Evaluate the ability of a slow-releasing formulation of neutral potassium phosphate to correct hypercalciuria and prevent recurrent stone formation in patients with absorptive hypercalciuria. II. Evaluate the safety of this treatment. III. Compare the efficacy of potassium phosphate to that of potassium citrate. |
| NCT00004284 ↗ | Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria | Completed | National Center for Research Resources (NCRR) | Phase 3 | 1995-04-01 | OBJECTIVES: I. Evaluate the ability of a slow-releasing formulation of neutral potassium phosphate to correct hypercalciuria and prevent recurrent stone formation in patients with absorptive hypercalciuria. II. Evaluate the safety of this treatment. III. Compare the efficacy of potassium phosphate to that of potassium citrate. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate
Condition Name
| Condition Name for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate | |
| Intervention | Trials |
| Healthy | 3 |
| Hyperkalemia | 2 |
| Respiratory Distress Syndrome, Adult | 2 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate
Trials by Country
Clinical Trial Progress for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate
Sponsor Name
| Sponsor Name for dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate | |
| Sponsor | Trials |
| University of Minnesota | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Rigshospitalet, Denmark | 2 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
